The most prevalent molecular subtype in NSCLC is EGFR-mutant, with a prevalence of 15–20% in adenocarcinomas of patients in Caucasian populations and up to 50% in Asian populations [88,95]. This evidence concerns the gene EGFR and adenocarcinoma.